Boston Scientific

Boston Scientific, we work collaboratively to solve healthcare’s toughest problems by developing solutions that matter most to those suffering from debilitating.

Launch date

1979

Employees

10001+ people

Market cap

Enterprise valuation

€119.5b (Public information from Sep 2024)

Marlborough Massachusetts (HQ)

http://www.bostonscientific.com/

https://twitter.com/bostonsci https://www.facebook.com/bostonscientific https://www.linkedin.com/company/boston-scientific

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	9.9b	11.9b	12.7b	14.2b	16.3b	18.0b	19.8b
% growth	(8 %)	20 %	7 %	12 %	14 %	11 %	10 %
EBITDA	1.8b	2.8b	2.8b	3.6b	4.8b	5.4b	6.1b
% EBITDA margin	18 %	23 %	22 %	25 %	29 %	30 %	31 %
Profit	(140m)	1.0b	698m	1.6b	2.1b	2.8b	3.3b
% profit margin	(1 %)	9 %	6 %	11 %	13 %	15 %	17 %
EV / revenue	5.9x	5.7x	5.9x	6.5x	7.8x	6.9x	6.1x
EV / EBITDA	32.1x	24.3x	26.5x	25.7x	26.5x	22.8x	19.7x
R&D budget	1.1b	1.2b	1.3b	1.4b	-	-	-
R&D % of revenue	12 %	10 %	10 %	10 %	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
May 1992	N/A	N/A	IPO
Feb 2018*	N/A	$1.0b	Post IPO Debt
May 2020*	N/A	$2.0b	Post IPO Equity
Mar 2022*	N/A	€3.0b	Post IPO Debt
Nov 2023*	railpen	$9.1m	Post IPO Equity
Jan 2024*	Ardevora Asset Management	$18.8m	Post IPO Equity
Feb 2024*	N/A	$2.0b	Post IPO Debt
Total Funding		-